paritaprevir

From Aaushi
Jump to navigation Jump to search

Indications

* including patients with cirrhosis

Dosage

Adverse effects

Mechanism of action

More general terms

Component of

References

  1. Orciari Herman A and Sofair A Viekira Pak Approved for Hepatitis C Physician's First Watch, Dec 22, 2014 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
    FDA News Release. Dec 19, 2014 FDA approves Viekira Pak to treat hepatitis C http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427530.htm
  2. 2.0 2.1 2.2 PERSPECTIVES FROM NEW ADVERSE EVENT REPORTS Institute for Safe Medication Practices. Jan 25, 2017 http://www.ismp.org/quarterwatch/pdfs/2016Q2.pdf